FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma

FGFR2 gene amplification and clinicopathological features in gastric cancer

(2012) K Matsumoto et al.   BRITISH JOURNAL OF CANCER

FOXQ1 Is Overexpressed in Colorectal Cancer and Enhances Tumorigenicity and Tumor Growth

(2010) H. Kaneda et al.   CANCER RESEARCH

mTOR Signal and Hypoxia-Inducible Factor-1  Regulate CD133 Expression in Cancer Cells

(2009) K. Matsumoto et al.   CANCER RESEARCH

Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: A case report

(2008) Brian J So et al.   Journal of Hematology & Oncology

A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization study

(2008) Yasuyo Chochi et al.   JOURNAL OF PATHOLOGY

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE